Intermediate endpoints as surrogates for long term outcomes in breast cancer adjuvant chemotherapy trials

By afschroeder • August 22, 2025

Blasco A, López-Tarruella S, Urruticoechea A, Carrasco E, Spera G, Martín M, Bermejo B, Chap L, Ruiz-Borrego M, Crown J, García-Saenz JA, Chan A, Guerrero-Zotano Á, Semiglazov V, Calvo L, Pienkowski T, Herranz J, Slamon D. Intermediate endpoints as surrogates for long term outcomes in breast cancer adjuvant chemotherapy trials. Oncologist. 2025 Aug 21:oyaf263. doi: 10.1093/oncolo/oyaf263. Epub ahead of print. PMID: 40838872.

Tags: adjuvant chemotherapy, breast cancer, Early-stage, Hematology/Oncology, Publications, surrogate endpoint

Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis

Zaorsky NG, Sun Y, Nabid A, Zapatero A, Bolla M, Joseph D, Maingon P, Guerrero A, Gonzalez AA, San-Segundo CG, Cabeza Rodríguez MÁ, Sole JM,[...]

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun[...]

Oncoplastic Breast Surgery: Optimizing Resection Margins in Addition to Aesthetic Outcomes

Yesantharao PS, Shaheen MS, Hui G, Gombar S, Momeni A. Oncoplastic Breast Surgery: Optimizing Resection Margins in Addition to Aesthetic Outcomes. Aesthetic Plast Surg. 2025[...]